Skip to main content
FinSpry Logo
FinSpry
BOLT logo
BOLT
(NASDAQ)
Bolt Biotherapeutics, Inc.
$4.36-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bolt Biotherapeutics (BOLT) Stock Price & Financial Analysis

Bolt Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.48 - $4.78
52-Week High$9.25
52-Week Low$3.91
Open$4.59
Volume16.24K
Average Volume (3M)27.35K
Market Cap8.26M
Shares Outstanding1.73M
Price to Sales (P/S)1.07
Price to Book (P/B)0.31
EV/EBITDA-0.59
Revenue (TTM)7.70M
Net Income (TTM)-33.38M
Free Cash Flow (TTM)-39.92M
EPS (TTM)$-17.85
Profit Margin-433.74%
Operating Margin-450.07%
Return on Equity (ROE)-125.92%
Debt to Equity0.87
50-Day MA$4.60
200-Day MA$5.23
52-Week Change-36.49%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bolt Biotherapeutics

What is the current stock price for BOLT?

As of the latest trading session, BOLT stock trades at $4.72. The 52-week range is $3.91–$9.25, with a day range of $4.48–$4.78.

What is the P/E ratio for BOLT?

The P/E ratio (Price-to-Earnings) for BOLT is shown in the Key Statistics section. This valuation metric helps compare Bolt Biotherapeutics, Inc. to industry peers.

Does BOLT pay dividends?

Bolt Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BOLT?

Based on 1 analyst, the consensus for BOLT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BOLT?

Bolt Biotherapeutics's market capitalization is $8.2M, classifying it as a micro-cap company. Bolt Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.